Literature DB >> 29760410

Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase.

Elisabeth G Vichaya1, Geoffroy Laumet2, Diana L Christian2, Aaron J Grossberg2, Darlene J Estrada2, Cobi J Heijnen2, Annemieke Kavelaars2, Robert Dantzer2.   

Abstract

Despite years of research, our understanding of the mechanisms by which inflammation induces depression is still limited. As clinical data points to a strong association between depression and motivational alterations, we sought to (1) characterize the motivational changes that are associated with inflammation in mice, and (2) determine if they depend on inflammation-induced activation of indoleamine 2,3 dioxygenase-1 (IDO1). Lipopolysaccharide (LPS)-treated or spared nerve injured (SNI) wild type (WT) and Ido1-/- mice underwent behavioral tests of antidepressant activity (e.g., forced swim test) and motivated behavior, including assessment of (1) reward expectancy using a food-related anticipatory activity task, (2) willingness to work for reward using a progressive ratio schedule of food reinforcement, (3) effort allocation using a concurrent choice task, and (4) ability to associate environmental cues with reward using conditioned place preference. LPS- and SNI-induced deficits in behavioral tests of antidepressant activity in WT but not Ido1-/- mice. Further, LPS decreased food related-anticipatory activity, reduced performance in the progressive ratio task, and shifted effort toward the preferred reward in the concurrent choice task. These effects were observed in both WT and Ido1-/- mice. Finally, SNI mice developed a conditioned place preference based on relief from pain in an IDO1-independent manner. These findings demonstrate that the motivational effects of inflammation do not require IDO1. Further, they indicate that the motivational component of inflammation-induced depression is mechanistically distinct from that measured by behavioral tests of antidepressant activity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29760410      PMCID: PMC6300560          DOI: 10.1038/s41386-018-0075-z

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

1.  Bodyweight, locomotion, and behavioral responses of the naked mole rat (Heterocephalus glaber) to lipopolysaccharide administration.

Authors:  Mosiany Letura Kisipan; Rodi Omondi Ojoo; Titus Ikusya Kanui; Klas S P Abelson
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2022-06-22       Impact factor: 2.389

Review 2.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

3.  Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.

Authors:  Geoffroy Laumet; Jules D Edralin; Robert Dantzer; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Pain       Date:  2019-06       Impact factor: 7.926

4.  Effects of chemotherapy on operant responding for palatable food in male and female mice.

Authors:  Julie A Meade; Alison N Fowlkes; Mackinsey J Wood; Mary Claire Kurtz; Madeline M May; Wisam B Toma; Urszula O Warncke; Jared Mann; Mohammed Mustafa; Aron H Lichtman; M Imad Damaj
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

5.  A Novel Syngeneic Immunocompetent Mouse Model of Head and Neck Cancer Pain Independent of Interleukin-1 Signaling.

Authors:  Matthew J Heussner; Joseph K Folger; Christina Dias; Noura Massri; Albert Dahdah; Paola D Vermeer; Geoffroy Laumet
Journal:  Anesth Analg       Date:  2021-04-01       Impact factor: 6.627

6.  Microglia depletion fails to abrogate inflammation-induced sickness in mice and rats.

Authors:  Elisabeth G Vichaya; Sajida Malik; Luba Sominsky; Bianca G Ford; Sarah J Spencer; Robert Dantzer
Journal:  J Neuroinflammation       Date:  2020-05-31       Impact factor: 8.322

7.  Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease.

Authors:  Giorgia Boero; Patrizia Porcu; A Leslie Morrow
Journal:  Neurobiol Stress       Date:  2019-11-27

8.  Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways.

Authors:  Jia Zhao; Yizhen Jia; Wei Zhao; Huixin Chen; Xiuying Zhang; Fung Yin Ngo; Dan Luo; Youqiang Song; Lixing Lao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

Review 9.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

10.  CD3+ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior.

Authors:  Geoffroy Laumet; Jules D Edralin; Robert Dantzer; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Neurobiol Pain       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.